Nammex Announces Scientific Advisory Board to Ensure Products, Processes, Research, Data and Communications are Supported by Scientific Evidence

Nammex Team
July 17, 2026

• 4 Mins Reading Time

Gibsons, BC, Canada (June 7, 2026) -- Nammex Mushrooms, Inc., the premier North American supplier of Certified Organic Functional Mushroom Extracts, has developed a Scientific Advisory Board (SAB) to provide independent, expert scientific guidance to the Nammex management team and Board of Directors on matters related to scientific substantiation, research design, analytical testing, quality systems, and ethical standards applicable to the development and commercialization of Nammex’s organic mushroom extracts and related fungi-derived ingredients, unique knowledge, and data. 

The SAB supports Nammex’s commitment to truthful, non-misleading, scientifically based labeling and marketing, scientifically accurate product characterization, and responsible innovation in functional mycology science. It also serves as an independent think tank producing generative ideation informed by a multidisciplinary group of passionate and dedicated experts.  

 “Nammex has always sought the opinion of other experts on scientific aspects of mushrooms and applied mycology and it seemed obvious to coalesce the individual efforts of our retained consultants into a group think tank.” said Bill Chioffi, Nammex COO. “While we anticipate expanding the membership, this core group brings significant expertise and innovative energy to Nammex.”

 The SAB members include:

Lee Carroll Medical Herbalist, Educator & Product Developer — Brisbane, Australia. Lee Carroll is a leading medical herbalist, innovator, speaker, educator, and mentor with over 30 years of experience in the herbal industry, 23 years teaching herbal medicine to healthcare professionals, and 11 years in private practice. He holds a Bachelor of Health Science (Western Herbal Medicine), BHSc (whm) and a Bachelor of Science (Botany), BSc from Melbourne University. 

Jeff Chilton Ethnomycologist, Chairman of the Board & Founder, Nammex. Jeff Chilton is a pioneering mycologist and entrepreneur who has been a foundational figure in the North American medicinal mushroom industry for over 50 years. He continues to serve as founder and president of Nammex, the first company to supply certified organic mushroom extracts to the supplement industry.

Steven Dentali, Ph.D. Botanical Ingredient Authority & Natural Product Chemist. Steven Dentali is an internationally recognized authority on botanical ingredients and natural product chemistry with over 30 years of post-graduate experience in the herbal supplement industry. He is the founder of Dentali Botanical Sciences and remains an active educator and consultant.

Dennis McKenna, Ph.D. Ethnopharmacologist, Research Pharmacognosist & Author. Dennis McKenna is an American ethnopharmacologist, research pharmacognosist, lecturer, and author. He is a founding board member and Director of Ethnopharmacology at the Heffter Research Institute, a non-profit dedicated to investigating the therapeutic potential of psychedelic medicines. Beyond his research in psychedelics, McKenna has been a pivotal figure in the natural products industry, serving as a trusted scientific advisor to Nammex and founder Jeff Chilton for decades.

Robert Silver, DVM, MS, FACVBM Integrative Veterinarian & Chief Veterinary Officer, Real Mushrooms. Dr. Robert Silver is a 1982 graduate of Colorado State University's College of Veterinary Medicine. He received his Master's degree in cardiopulmonary physiology (1976) and his Bachelor's degree with honors in Animal Science (1974), both from CSU.

Anna Sitkoff, N.D. Naturopathic Doctor & Medicinal Mushroom Researcher — Private Practice, Poulsbo, WA. Dr. Anna Sitkoff is a licensed naturopathic doctor, medicinal mushroom expert, and researcher specializing in applied mycology — the clinical application of fungi in wellness and disease. She earned her Doctorate of Naturopathic Medicine from Bastyr University, where she conducted laboratory research on Fomitopsis cajanderi (rosy polypore) and its effects on cancer cell lines.

Kevin Spelman, Ph.D., MCPP Botanical Medicine Pharmacologist, Clinician & Researcher. Kevin Spelman is a clinician, researcher, and educator whose expertise lies in the pharmacology of botanical medicine. He brings three decades of clinical work in Ayurveda and western phytotherapy, academic professorships, and a decade of laboratory and clinical research.

The SAB will engage periodically with Nammex leadership, including the CEO, Chief Operating Officer, and QPIC/Lab Director, to maintain alignment between scientific guidance and corporate strategy. All members, who are compensated by Nammex for their time, are required to disclose potential conflicts of interest promptly and transparently.

Articles You Might Be Interested In

Nammex Introduces ErinaPrime Pure Lion’s Mane Mycelium Ingredient Free of Grain or Fillers Through Exclusive Partnership with Novelara
Gibsons, BC, Canada (June 1, 2026) -- Nammex Mushrooms, Inc., the premier North American supplier of Certified Organic Functional Mushroom Extracts, i...
Nammex Highlights Urgent Need for Authenticated Fungal Reference Materials at ICSB 2026
Gibsons, British Columbia (April 7, 2026) — Nammex Mushrooms, Inc will give two scientific presentations at the International Congress on Science of...
Nammex Clarifies Findings on Comparative Study of Dietary Supplements Labeled as “Chaga”
Multiple Suppliers Join This Call for Accurate Labeling & Best Practices Gibsons, BC, Canada (June 3, 2025) – Nammex, the premier North American...

Nammex Insider Offers

Stay up to date with the latest news, announcements, and articles.

    Your information is 100% confidential and privately stored.